Navigation Links
Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting

Four Posters Relating to Company Oncology Programs to be Presented

SOUTH SAN FRANCISCO, Calif., April 09, 2007 /PRNewswire-FirstCall/ -- Cytokinetics, Incorporated announced today that four posters containing non-clinical data will be presented at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) to be held from April 14- 18, 2007 in Los Angeles, CA. These posters are related to multiple oncology programs at Cytokinetics and will present data evaluating ispinesib, a novel inhibitor of Kinesin Spindle Protein (KSP), in models of multiple myeloma, data evaluating GSK-923295, a novel inhibitor of centrosome associated protein E (CENP-E) in both biochemical assays and in xenograft models and data from a separate, novel Cytokinetics' cell-based drug discovery program.

    Poster Presentations at 2007 AACR Annual Meeting


    Ispinesib:


     Abstract #1435:  Kinesin Spindle Protein Inhibition for the Treatment of

     Multiple Myeloma. (Poster displayed on Sunday, April 15, 2007, 1:00 PM -

     5:00 PM, PT, Poster Section 27, Poster Board 16.)


    GSK-923295:


     Abstract #1522:  GSK-923295, a Potent and Selective CENP-E Inhibitor, Has

     Broad Spectrum Activity Against Human Tumor Xenografts in Nude Mice.

    (Poster displayed on Sunday, April 15, 2007, 1:00 PM - 5:00 PM, PT, Poster

     Section 31, Poster Board 8.)


     Abstract #3179:  Detailed Biochemical Analysis of the CENP-E Inhibitor

     GSK-923295. (Poster displayed on Monday, April 16, 2007, 1:00 PM - 5:00

     PM, PT, Poster Section 26, Poster Board 18.)


    Cell-based Drug Discovery Program:


     Abstract #5576:  Cell-based Discovery and Anti-tumor Activity of a Novel

     Mitotic Inhibitor. (Poster displayed on Wednesday, April 18, 2007, 8:00

     AM -12:00 PM, PT, Poster Section 27, Poster Board 14.)

Ispinesib has been the subject of a broad Phase II clinical trials program unde
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:7/31/2015)... HYDERABAD, India , July 31, 2015 /PRNewswire/ ... Billing and CRM solutions for video, data and cloud ... (PoC) with a leading pharma giant for Internet ... managing different IoT applications offered on subscription model. ... Pharma giant is striving for business ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
(Date:7/30/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today ... Agreements with Dexcom, Inc. to allow the integration ... Dexcom G5 and G6 continuous glucose monitoring ("CGM") ... platform with Dexcom,s future CGM systems is an ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... , , , , ... i c , Inc. (Nasdaq: ... medical imaging systems and surgical products dedicated to serving the healthcare needs ... study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic ...
... VIENNA, Va., Aug. 18 CEL-SCI Corporation (NYSE Amex: ... of its work towards creating a novel treatment and vaccination against ... in which the virus has acquired greater morbidity and mortality. ... are highly conserved and essential for the virus, survival. This ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4CEL-SCI Expands H1N1 Flu Virus Work 2CEL-SCI Expands H1N1 Flu Virus Work 3
(Date:7/31/2015)... ... July 31, 2015 , ... ... announce that their latest designer handbag line will be named for Madeline Stuart, ... sensation as the first globally recognized model with Down syndrome, gracing the front ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... has announced plans to release a newly redesigned website at Healthpointe.net. The new ... enhanced user experience. , The redesign serves to provide smoother interactions between ...
(Date:7/31/2015)... ... , ... ZH Healthcare announces a new cloud based service delivering Health IT ... a Service (HITaaS) is a Healthcare dedicated cloud based service that sits over infrastructure ... manages all aspects of infrastructure, security, runtime, middleware, OS, virtualization, Servers, storage, contracts, ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Medicine Practice, and Hospital Medicine Practice, is pleased to announce that it has ... mobile application format available on iPhones, iPads, and Android smartphones and tablets. ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Radiology ... Michael Burgess, MD, (R-Tex) presenting “What’s Next for Health Care: A View From Capitol ... and founder of the Congressional Health Caucus, Rep. Burgess has a special understanding of ...
Breaking Medicine News(10 mins):Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3Health News:Healthpointe Announces Newly Redesigned Website 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3
... Provides Best-of-Suite Technology, Streamlines ... ... Oct. 23 ,Medsphere Systems Corporation and Keane, Inc. today announced ... integrated best-of-suite clinical and financial software. The alliance,leverages Medsphere,s OpenVista(R) ...
... Palmetto GBA, a leading,provider of technical and administrative ... selected as a subcontractor as part,of a contract awarded ... for information technology modernization. Palmetto GBA is part ... for the unrestricted portions of CMS, Enterprise System,Development (ESD) ...
... incentives to health workers in low-income countries may hold the ... young children, according to a study published on bmj.com ... expert panel as one of eight of the most outstanding ... policy and will be presented at the launch of the ...
... Brings Additional Key Gene Locus as a ... for Recently-Funded Company, NEW HAVEN, Conn., Oct. 23 ... diagnose dry and wet Age-related Macular,Degeneration (AMD) and other ... it has licensed from the University,of Pittsburgh the worldwide ...
... Oct. 23 GeneGo, Inc., a leading,provider of ... they have licensed their MetaCore Data Mining Suite ... novel GeneGo,disease enrichment and functional ontology. MetaCore has ... the unique ability to concurrently,visualize gene expression, proteomics, ...
... designed to connect healthcare communities throughout ... ... During the World of,Health IT Conference and Exhibition today in Vienna, ... broad expansion of the Microsoft Healthcare Users Group (MS-HUG) to,partners and ...
Cached Medicine News:Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 2Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 3Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 4Health News:Palmetto GBA Selected as Subcontractor for CMS' Enterprise System Development Project 2Health News:Financial incentives may hold key to cutting child malaria deaths 2Health News:Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations 2Health News:Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations 3Health News:GeneGo Licenses MetaCore Data Analysis Suite to AVEO Pharmaceuticals 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 3Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with particulate (silica) activator....
Medicine Products: